Increased levels of hypoxia‐inducible factor‐1α are associated with Bcl‐xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma
Open Access
- 22 November 2010
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 29 (1) , 143-151
Abstract
Hypoxia‐inducible factor (HIF)‐1α is a key nuclear transcription factor that regulates the cellular response to hypoxia, and is important for solid tumor growth and survival. However, the underlying role of HIF‐1α in human chondrosarcoma has not been well characterized. This study aims to investigate the expression patterns of HIF‐1α in chondrosarcoma, and its association with clinicopathologic features, Bcl‐xL expression, apoptosis index (AI), and overall survival of patients with chondrosarcoma. Our results shown that the protein levels of HIF‐1α were increased, and the mRNA and protein levels of Bcl‐xL were also increased in SW1353 cells under hypoxic conditions. In eight patients with chondrosarcoma, increased expression of HIF‐1α and Bcl‐xL was detected in chondrosarcoma tissues compared with the paired adjacent normal tissues. Of 34 archival specimens of chondrosarcomas, 20 (58.8%) showed high HIF‐1α protein expression as compared to benign cartilage tumors. Increased HIF‐1α expression was correlated with a higher pathological grade and MSTS stage of chondrosarcoma. Moreover, HIF‐1α expression was significantly associated with Bcl‐xL expression and AI. More significantly, the survival rate of patients with HIF‐1α high tumors was significantly lower than that of patients with HIF‐1α low tumors. These findings suggest that increased HIF‐1α levels mediated up‐regulation of Bcl‐xL play a prominent role in evasion of apoptosis and tumor progression, and can be predictive for the prognosis in human chondrosarcoma. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:143–151, 2011Keywords
This publication has 39 references indexed in Scilit:
- BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1αJournal of Biological Chemistry, 2009
- EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal CancerJournal of Clinical Oncology, 2008
- The role of hypoxia-inducible factors in tumorigenesisCell Death & Differentiation, 2008
- Pathology of primary malignant bone and cartilage tumoursInternational Orthopaedics, 2006
- Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human CancersPLOS Medicine, 2006
- Expression of hypoxia-inducible factor (HIF)-1α is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinomaEuropean Journal of Cancer, 2004
- Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)Biochemical and Biophysical Research Communications, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor proteinThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000